dendrit
cell
dc
highli
special
antigen
present
cell
immun
system
play
key
role
regul
immun
respons
depend
method
antigen
deliveri
dc
stimul
immun
respons
induc
toler
consequ
dual
function
dc
dc
studi
context
immunotherapi
cancer
autoimmun
diseas
vaccin
develop
major
aim
induc
strong
specif
tcell
respons
achiev
target
antigen
cell
surfac
molecul
dc
effici
channel
antigen
endocyt
compart
load
onto
mhc
molecul
stimul
tcell
respons
attract
cell
surfac
receptor
express
dc
use
target
antigen
deliveri
cancer
diseas
discuss
success
vaccin
use
combat
infecti
diseas
live
live
attenu
organ
use
polio
small
pox
vaccin
howev
purifi
protein
peptid
case
adjuv
suitabl
danger
signal
necessari
order
prime
tcell
respons
last
decad
dendrit
cell
dc
power
antigen
present
cell
surfac
import
cell
target
antigen
uptak
process
present
cell
dc
link
innat
immun
respons
adapt
immun
respons
bind
pathogen
abl
stimul
tcell
respons
antigen
target
antigen
dc
therefor
appropri
method
stimul
effect
immun
respons
target
cell
surfac
receptor
dc
repres
direct
less
labori
method
subject
consider
recent
investig
numer
receptor
identifi
express
dc
includ
mannos
receptor
mr
dcsign
scaveng
receptor
sr
tolllik
receptor
target
receptor
becom
effici
strategi
deliv
antigen
dcbase
anticanc
immunotherapi
furthermor
pattern
recognit
receptor
prr
express
cell
innat
immun
system
bind
pathogen
associ
molecular
pattern
pamp
pathogen
prr
also
known
pathogen
recognit
receptor
primit
pattern
recognit
receptor
evolv
part
immun
system
mainli
adapt
immun
pamp
bind
mannos
lipopolysaccharid
fucos
peptidoglycan
lipoprotein
glucan
prr
classifi
group
endocyt
prr
phagocytos
microorgan
bind
carbohydr
includ
mannos
receptor
mr
glucan
receptor
scaveng
receptor
ii
signal
prr
includ
membran
bound
tolllik
receptor
tlr
cytoplasm
nodlik
receptor
membran
bound
receptor
fall
categori
receptor
kinas
ii
tlr
iii
ctype
lectin
receptor
target
receptor
becom
effici
strategi
deliv
antigen
dcbase
anticanc
immunotherapi
calciumdepend
ctype
lectin
consist
larg
famili
lectin
consist
carbohydr
recognit
domain
ctype
lectin
famili
includ
mannos
receptor
mannos
bind
lectin
ficolin
activ
immunesystem
function
pathogen
recognit
addit
dendrit
cell
ctype
lectin
dcsign
dcsignr
dcar
dcir
dectin
dlec
import
dendrit
cell
traffick
format
immunolog
synaps
induc
cellular
humor
immun
bring
togeth
adapt
innat
immun
figur
figur
mr
bind
carbohydr
present
cell
wall
yeast
virus
bacteria
lead
endocytosi
phagocytosi
interestingli
human
immunodefici
viru
hiv
bind
mr
vagin
epitheli
cell
induc
product
matrix
metalloproteinas
facilit
transport
hiv
across
vagin
epithelium
addit
hiv
bind
mannos
receptor
sperm
cell
suggest
sperm
cellhiv
interact
import
sourc
infect
mr
part
multilectin
receptor
famili
provid
link
innat
adapt
immun
two
type
mr
human
encod
gene
mannos
receptor
c
type
ii
mannos
receptor
c
type
mr
use
target
vaccin
dc
take
mannosyl
protein
util
peptid
epitop
antigen
present
high
express
mr
dc
macrophag
suggest
mr
play
key
role
antigen
recognit
uptak
antigen
mr
allow
process
present
via
mhc
class
ii
pathway
henc
suggest
mr
viabl
target
homolog
part
cluster
also
term
express
granulocyt
monocyt
macrophag
b
cell
cell
peripher
blood
dc
express
nk
cell
monocyt
granulocyt
platelet
megakaryocyt
liver
sinusoid
epitheli
cell
bind
facilit
spread
cell
bind
snake
venom
rhodocytin
much
known
regard
stimul
immun
respons
howev
coloc
dcsign
suggest
may
immun
stimulatori
effect
part
nk
gene
cluster
ctype
lectin
receptor
express
macrophag
monocyt
dc
much
known
regard
function
antigen
deliveri
vaccin
develop
inde
mannosyl
peptid
protein
stimul
mhc
class
ii
specif
cell
higher
effici
compar
peptid
protein
mannosyl
enhanc
present
solubl
antigen
cell
intern
mr
dc
compar
antigen
intern
via
fluid
phase
antigen
conjug
oxid
mannan
polymannos
compris
aldehyd
lead
rapid
time
effici
mhc
class
present
cell
preferenti
respons
compar
antigen
conjug
reduc
mannan
aldehyd
antigen
conjug
reduc
mannan
result
class
ii
present
immun
respons
conjug
formul
oxid
reduc
mannan
bind
equal
mr
taken
earli
endosom
mannan
rapidli
escap
earli
endosom
cytosol
proteasom
process
transport
endoplasm
reticulum
golgi
apparatu
mhc
class
cell
surfac
contrast
mannan
remain
earli
endosom
late
endosom
lysosom
result
mhc
class
ii
present
antigen
furthermor
oxid
reduc
mannan
stimul
bone
marrow
deriv
dc
show
enhanc
allogen
tcell
prolifer
enhanc
otiotii
peptid
specif
tcell
respons
vitro
mice
inject
oxid
reduc
mannan
induc
matur
phenotyp
lymph
node
splenic
dc
oxid
reduc
mannan
stimul
upregul
inflammatori
cytokin
interleukin
il
tumour
necrosi
factoralpha
howev
oxid
mannan
stimul
ifngamma
cytokin
wherea
reduc
mannan
stimul
moreov
activ
dc
tolllik
depend
thu
mode
mannan
conjug
antigen
import
differenti
immun
respons
result
studi
provid
first
demonstr
mr
aid
antigen
mhc
class
ii
pathway
depend
chemic
modif
mannan
addit
ex
vivo
target
macrophag
dc
oxid
reinject
mice
induc
strong
ctl
respons
protect
tumor
challeng
human
inject
oxid
induc
cellular
humor
immun
respons
protect
recurr
breast
cancer
patient
thu
mannan
oxid
form
shown
effect
anticanc
vaccin
mannan
reduc
form
show
promis
vaccin
autoimmun
diseas
multipl
sclerosi
dna
immun
attract
form
vaccin
shown
promis
result
small
anim
model
target
mr
dna
vaccin
viabl
approach
ration
design
dna
vaccin
strategi
mannosyl
liposom
incorpor
ova
dna
induc
strong
ctl
respons
mice
compar
nonmannosyl
complex
complex
oxid
reduc
mannan
ova
dna
via
polyllysin
abl
stimul
strong
cellular
humor
immun
respons
mice
use
dna
complex
oxid
reduc
mannan
immunogen
tcell
respons
ifngamma
secret
low
dose
administr
tumor
protect
compar
dna
alon
anoth
approach
cation
amphiphil
contain
mannos
mimic
quinic
acid
shikim
acid
headgroup
abl
target
mr
dc
lead
effect
immun
respons
tumor
protect
suggest
mannosyl
dna
effect
approach
gener
immun
respons
dendrim
repetit
branch
molecul
adopt
spheric
morpholog
dendrim
major
part
core
inner
shell
outer
shell
attach
compound
could
ad
attempt
develop
novel
immunotherapeut
mannosyl
dendrim
ova
shown
taken
process
present
bone
marrow
deriv
dc
dc
mannosyl
dendrim
ova
stimul
tcell
respons
antibodi
protect
mice
ova
tumor
challeng
mannosyl
dendrim
ova
induc
dc
matur
larg
depend
mannan
coat
cation
liposom
nanoparticl
incorpor
dna
stimul
cytotox
lymphocyt
ctl
ifngamma
iga
delayedtyp
hypersensit
respons
bind
uptak
properti
mannan
coat
nanoparticl
higher
compar
nonmannan
coat
nanoparticl
mr
cell
line
bind
uptak
inhibit
presenc
free
mannan
suggest
uptak
receptor
depend
anion
liposom
hand
bilay
composit
phosphatidylcholin
cholesterol
phosphatidylglycerol
phosphatidylserin
bind
dc
howev
mannosyl
anion
liposom
increas
interact
murin
human
dc
could
block
free
mannan
thu
type
liposom
import
develop
effect
vaccin
although
mannan
coat
could
overcom
pitfal
mannosyl
liposom
incorpor
ctl
helper
peptid
synthet
agonist
induc
higher
therapeut
efficaci
compar
nonmannosyl
liposom
addit
mannosyl
liposom
bind
endocytoz
immatur
dc
howev
nonspecif
endocytosi
observ
nonmannosyl
liposom
liposom
conatin
multibranch
mannosyl
lipid
bind
higher
affin
mr
lead
effect
uptak
endocytosi
compar
liposom
contain
monomannosyl
analog
furthermor
mannan
coat
poli
llactidecoglycol
acid
plga
nanoparticl
enhanc
tcell
respons
compar
nonmannan
coat
nanoparticl
addit
protein
complex
cholesteryl
groupbear
mannan
pullulan
polysaccharid
gener
ctl
reject
tumor
mice
furthermor
mannosyl
chitosan
microspher
mcm
incorpor
bordetella
bronchiseptica
antigen
bound
mr
murin
macrophag
cell
vitro
induc
strong
iga
antibodi
respons
vivo
howev
mannos
coat
stealth
microspher
although
bound
mr
abl
matur
dc
vitro
four
lipidcor
peptid
synthes
contain
sequenc
human
papillomaviru
protein
dmannos
immun
mice
peptid
reduc
clear
tumor
effect
compar
mice
immun
nonmannosyl
peptid
numer
vaccin
use
keyhol
limpet
hemocyanin
klh
aid
antibodi
tcell
respons
klh
activ
matur
dc
upregul
mhc
class
ii
cell
surfac
molecul
stimul
cytokin
interact
klh
dc
note
partial
mediat
bind
mr
cluster
differenti
protein
particular
express
macrophag
dc
present
lipid
antigen
includ
lipid
mycol
acid
lipoarabinomannan
cell
antigen
present
pathway
lipoarabinomannan
character
mr
clearli
respons
uptak
lipoarabinomannan
endocytoz
earli
endosom
via
mr
late
endosom
load
onto
molecul
tcell
present
studi
link
mr
present
glycolipid
via
suggest
mr
play
major
function
role
process
carbohydr
antigen
melanoma
associ
antigen
fuse
heavi
chain
antimr
antibodi
puls
dc
result
mhc
class
class
ii
present
ctl
gener
likewis
human
chorion
gonadotropin
beta
protein
express
cancer
cell
coupl
antimr
antibodi
gener
mhc
class
class
ii
tcell
respons
lyse
hcgbeta
cell
line
helper
cell
ctl
cancer
patient
healthi
subject
effect
prime
puls
dc
combin
tlrligand
use
evid
poli
c
ligand
resiquimod
ligand
use
concomit
signal
dc
led
effici
antigen
present
mr
target
thu
mr
tlr
togeth
contribut
toward
matur
activ
dc
human
clinic
trial
well
toler
strong
immun
respons
cancer
patient
phase
ii
studi
current
progress
similarli
cancertesti
ag
wide
use
clinic
cancer
vaccin
trial
fuse
either
antimr
antibodi
antibodi
bound
mr
dc
dc
lead
stimul
cell
peripher
blood
mononuclear
cell
cancer
patient
contrast
nonantibodi
target
protein
activ
cell
thu
target
either
mr
dc
promis
vaccin
strategi
induc
strong
cellular
immun
respons
order
retain
characterist
mannos
rich
carbohydr
target
mr
dc
antigen
express
yeast
sever
recombin
ovalbumin
ova
protein
gener
pichia
pastori
natur
mannosyl
ova
mannosyl
ova
induc
enhanc
antigenspecif
tcell
prolifer
compar
nonmannosyl
ova
uptak
primarili
due
mannosespecif
ctype
lectin
receptor
mr
dcsign
stronger
ctl
respons
ifngamma
cytokin
induc
vaccin
mice
studi
demonstr
yeast
deriv
mannosyl
antigen
enhanc
immunogen
therapeut
strategi
use
tumorspecif
immunoglobulin
idiotyp
id
lymphoma
promis
id
protein
usual
produc
via
tumormyeloma
hybridoma
recombin
method
mammalian
bacteria
insect
cell
use
insect
cell
id
produc
contain
mannos
residu
enhanc
immunostimulatori
properti
activ
dc
tcell
stimul
erad
lymphoma
compar
id
protein
made
mammalian
cell
howev
antilymphoma
antibodi
gener
id
insect
cell
compar
mammalian
cell
similar
thu
insect
deriv
antigen
far
immunostimulatori
compar
mammalian
deriv
antigen
primarili
due
express
mannos
bind
mr
human
suppress
cell
high
preval
cryptococcosi
solubl
cryptococcu
neoforman
mannoprotein
mp
promis
vaccin
candid
due
abil
induc
delayedtyp
hypersensit
cytokin
mp
bind
mr
result
tcell
stimul
induc
protect
respons
c
neoforman
candida
albican
uptak
mp
dc
inhibit
either
competit
blockad
mr
remov
carbohydr
residu
critic
recognit
mp
increas
express
mhc
class
ii
cell
surfac
moleul
lead
matur
activ
dc
clear
mannos
group
mp
provid
immunogen
cryptococc
mp
find
support
vaccin
strategi
target
mr
clear
antigen
mannosyl
effect
approach
potenti
antigen
immunogen
due
enhanc
antigen
uptak
present
dc
macrophag
receptor
famili
dendrit
cellspecif
intercellular
adhes
nonintegrin
dcsign
also
known
ctype
membran
lectin
abundantli
express
immatur
dc
macrophag
endotheli
vascular
cell
atherosclerot
plaqu
lymphat
vessel
plasmacytoid
dc
tabl
figur
like
mr
dcsign
recogn
carbohydr
includ
mannos
fucos
nacetylgalactosamin
nacetylgiucosamin
residu
pathogen
mediat
endocytosi
thu
activ
tailor
adapt
immun
respons
pathogen
dcsign
also
bind
yeast
deriv
mannan
lewi
blood
group
antigen
sialyl
sulfat
le
x
complet
abrog
bind
dcsign
dcsign
contribut
hiv
pathogenesi
bind
dcsign
monocyt
deriv
dc
residu
bind
oppos
bind
blood
dc
bind
dcsign
dc
transport
dc
lymphoid
tissu
consequ
facilit
infect
target
cell
dog
allergen
bind
dcsign
e
coli
klebsiella
pneumonia
pseudomona
aeruginosa
staphylococcu
aureu
dcsign
identifi
high
affin
interact
facilit
dc
interact
cell
contribut
regul
primari
immun
respons
dcsign
also
interact
respons
dc
migrat
view
find
dcsign
implic
antigen
target
stimul
tcell
respons
studi
potenti
receptor
vaccin
target
order
understand
molecular
basi
intern
ligand
dcsign
put
intern
motif
within
cytoplasm
tail
modifi
result
reduc
intern
exposur
antigen
dcsign
ligand
complex
intern
dc
late
endosom
earli
lysosom
process
present
cell
antidcsign
monoclon
antibodi
intern
effici
compar
control
monoclon
antibodi
found
intracellular
vesicl
indic
target
dcsign
target
mhc
class
ii
pathway
antidcsign
monoclon
antibodi
conjug
klh
rapidli
intern
lysosom
compart
dc
induc
increas
stimul
cell
compar
klh
alon
puls
dc
addit
antidcsign
antibodyklhtarget
dc
induc
prolifer
naiv
cell
recogn
klh
tcell
epitop
present
mhc
class
ii
molecul
inhibit
tumor
cell
growth
mice
studi
use
antidcsign
monoclon
antibodi
bind
carbohydr
recognit
domain
recent
antidcsign
monoclon
antibodi
bind
neck
region
dcsign
rapidli
intern
earli
endosom
dc
clathrinindepend
mechan
unlik
antidcsign
antibodi
target
carbohydr
recognit
domain
intern
late
endosom
via
clathrin
depend
mechan
enhanc
tcell
stimul
result
use
antineck
region
antibodi
henc
target
differ
region
result
distinct
intern
mode
show
potenti
target
vaccin
strategi
hamster
bone
marrow
deriv
dc
express
high
level
dcsign
puls
tumor
lysat
hamster
pancreat
cell
inject
tumor
bear
hamster
reduc
tumor
growth
significantli
demonstr
target
dcsign
receptor
may
use
develop
effect
vaccin
liposom
contain
calcein
rapidli
taken
immatur
matur
myeloid
dc
nanoparticl
microparticl
deliv
antigen
human
dc
via
dcsign
vitro
demonstr
dcsign
target
receptor
vaccin
design
melanoma
antigen
peptid
contain
restrict
tcell
epitop
amino
acid
coupl
either
man
lactosid
lewi
oligosaccharid
glycoconjug
contain
lewi
oligosaccarid
bound
high
affin
dcsign
taken
dc
acid
vesicl
present
mhc
class
stimul
tcell
respons
howev
glycoconjug
contain
lactosid
taken
dc
modif
melanoma
antigen
glycan
high
mannos
interact
specif
dc
induc
enhanc
tcell
respons
le
x
oligosaccharid
conjug
ova
target
dcsign
dc
effect
stimul
ctl
ifngamma
secret
cell
requir
lower
dose
immun
compar
ova
immun
alon
use
human
dcsign
transgen
dc
le
x
ova
effici
endocytoz
enhanc
oti
otii
tcell
stimul
result
compar
ova
alon
heparanas
tumor
antigen
abl
elicit
immun
respons
howev
conjug
heparanas
le
x
abl
stimul
ifngamma
cytokin
secret
cell
ctl
respons
delay
growth
establish
tumor
mice
liposom
modifi
express
le
x
leb
increas
bind
intern
human
dc
enhanc
stimul
tcell
respons
presenc
lipopolysaccharid
compar
nonmodifi
liposom
addit
modifi
liposomel
x
leb
encapsul
melanoma
antigen
presenc
lipopolysaccharid
also
enhanc
tcell
clone
activ
vitro
polyamidoamin
dendrim
compris
leb
antigen
taken
lysosom
dendrim
contain
least
glycan
unit
necessari
antigen
present
cytokin
product
thu
complex
use
le
oligosaccharid
target
dcsign
repres
novel
method
vaccin
tumor
antigen
likewis
lentiviru
vector
modifi
sindbi
viru
envelop
protein
link
ova
taken
murin
bone
marrow
deriv
dc
stimul
oti
otii
cell
ctl
vivo
protect
mice
challeng
ova
express
tumor
cell
bind
modifi
lentiviru
vector
sindbi
viru
envelop
protein
dcsign
mannos
depend
modif
vector
includ
inhibit
mannosidas
enzym
remov
mannos
structur
glycosyl
result
enhanc
antibodi
respons
studi
demonstr
glycoconjug
could
design
target
dcsign
develop
tumor
vaccin
use
glycan
target
dcsign
advantag
antidcsign
monoclon
antibodi
reduc
risk
side
effect
gener
reli
pure
organ
chemistri
approach
howev
recent
studi
demonstr
receptorspecif
antibodi
effect
induc
immun
respons
carbohydr
glycan
dctarget
vaccin
strategi
lsign
dcsignr
lsign
dcsignr
also
known
typeii
transmembran
ctype
lectin
receptor
homolog
dcsign
amino
acid
sequenc
homolog
highli
express
liver
sinusoid
cell
endotheli
vascular
cell
lymph
node
dc
contrast
dcsign
tabl
figur
like
dcsign
lsign
high
affin
bind
hiv
simian
immunodefici
viru
journal
drug
deliveri
ebola
viru
hepat
c
viru
respiratori
syncyti
viru
lsign
also
bind
hiv
protein
oligosaccharid
bind
enhanc
disaccharid
antibodi
lsign
taken
human
liver
sinusoid
endotheli
cell
crossreact
antibodi
lsigndcsign
conjug
tetanu
toxoid
induc
tcell
respons
tetanu
toxoid
thu
target
lsign
show
promis
develop
target
vaccin
homolog
human
dcsign
document
signrel
gene
carbohydr
specif
similar
dcsign
bind
mannoseand
fucosecontain
ligand
interact
lewi
blood
antigen
howev
also
interact
sialyl
le
x
ligand
selectin
also
bind
zymosan
capsular
polysaccharid
pneumonia
low
affin
dextran
highli
express
macrophag
bovin
serum
antigen
bsa
consist
mannosid
residu
man
bsa
bind
lamina
propria
dc
gastrointestin
tract
induc
cytokin
secret
dc
vitro
vivo
man
bsa
stimul
type
regulatori
tlike
cell
regulatori
cell
suggest
induc
toler
antigen
lsectin
lsectin
liver
lymph
node
sinusoid
endotheli
cell
ctype
lectin
typeii
transmembran
ctype
lectin
protein
similar
relat
protein
dcsign
lsign
express
liver
lymph
node
cell
sinusoid
endotheli
cell
monocyt
deriv
dc
tabl
lsectin
bind
nacetylglucosamin
fucos
bind
galactos
may
function
vivo
lectin
receptor
lsectin
coexpress
dcsignr
bind
ebola
viru
filoviru
glycoprotein
lymphocyt
choriomening
viru
sprotein
sar
coronaviru
interact
hepat
c
although
studi
suggest
lsectin
bind
hepat
c
viru
interact
associ
dcsignr
ligand
bind
lsectin
inhibit
mannan
edta
suggest
lsectin
bind
mannos
recent
lsectin
shown
bind
anoth
studi
regard
express
lsectin
demonstr
lsectin
express
human
peripher
blood
thymic
dc
monocytederiv
macrophag
dc
human
kupffer
cell
antibodi
ligandmedi
engag
lsectin
activ
rapid
intern
lsectin
indic
lsectin
may
suitabl
receptor
target
antigen
develop
vaccin
regim
work
requir
determin
viabil
lsectin
appropri
target
immunotherapi
studi
cire
cire
ctype
lectin
immun
receptor
murin
type
membran
protein
belong
ctype
lectin
receptor
preferenti
express
immatur
splenic
dc
dc
plasmacytoid
predc
express
dc
macrophag
monocyt
tabl
figur
cire
ident
dcsign
murin
homolog
human
dcsign
bind
mannos
residu
howev
cire
downregul
activ
incub
cytokin
enhanc
express
cire
even
though
dcsign
enhanc
suggest
differ
gene
regul
two
receptor
cire
consist
amino
acid
extracellular
domain
contain
ctype
lectin
domain
ligand
receptor
hiv
bind
facilit
transinfect
cell
importantli
cire
bind
ebola
viru
glycoprotein
leishmania
mexicana
cytomegaloviru
lentiviru
defin
ligand
dcsign
lack
interact
due
defect
multimer
cire
thought
necessari
pathogen
recognit
dcsign
suggest
cire
dcsign
function
differ
polyanhydrid
nanoparticl
coval
link
dmannos
lactos
increas
cell
surfac
express
mhc
class
ii
cire
mr
bone
marrow
deriv
dc
compar
nonmodifi
nanoparticl
although
nanoparticl
similarli
intern
addit
polyanhydrid
nanoparticl
link
galactos
dmannos
increas
cell
surfac
express
mhc
class
ii
cire
mr
macrphag
galactos
lectin
proinflammatori
cytokin
tnfalpha
alveolar
macrophag
likewis
polyanhydrid
microparticl
link
pcarboxyphenoxi
hexan
cph
sebac
acid
pcarboxyphenoxi
cph
rapidli
phagocytos
within
hour
bone
marrow
deriv
dc
increas
cell
surfac
express
mhc
class
ii
cire
cytokin
conjug
microparticl
ova
stimul
oti
otii
cell
block
mr
cire
inhibit
upregul
cell
surfac
molecul
dc
suggest
cire
mr
engag
togeth
dc
activ
cire
show
promis
appropri
target
antigen
deliveri
improv
vaccin
develop
langerin
typeii
transmembran
cell
surfac
receptor
highli
express
langerhan
cell
dc
splenic
dc
tabl
langerin
ctype
lectin
highli
bind
mannos
residu
intern
dc
birbeck
granul
langerin
local
access
nonclass
antigen
process
present
pathway
compar
studi
murin
dcsign
langerin
demonstr
function
differ
amongst
differ
ctype
lectin
despit
similar
carbohydr
recognit
domain
murin
dcsign
bind
dextran
ova
zymosan
heatkil
candida
albican
langerin
show
distinct
carbohydr
recognit
bound
escherichia
coli
salmonella
typhimurium
gramneg
bacteria
neither
murin
dcsign
langerin
bound
staphylococcu
aureu
gramposit
bacteria
addit
lectin
receptor
distinct
bound
zymosan
langerhan
cell
subset
dc
divid
two
group
langerhan
cell
express
langerin
ii
epiderm
langerhan
cell
go
lymph
node
function
develop
independ
antilangerin
monoclon
antibodi
target
langerin
effici
endocytoz
langerhan
cell
vitro
vivo
suggest
studi
immun
skin
dcbase
vaccin
therapi
inde
antilangerin
monoclon
antibodi
conjug
hiv
induc
tcell
respons
mice
interestingli
monoclon
antibodi
recent
shown
taken
langerinposit
dc
suggest
crosstalk
langerin
receptor
noncoval
fusion
antilangerin
monoclon
antibodi
influenza
hemagglutinin
elicit
antigenspecif
tcell
antibodi
respons
vitro
vivo
acetylgalactosaminespecif
ctype
lectin
classic
asialoglycoprotein
receptor
figur
mgl
highli
express
macrophag
immatur
dc
whose
ligand
specif
differ
dcsign
lsign
bind
galactos
nacetylgalactosamin
lead
skew
immun
addit
mgl
bind
strongest
serin
threonin
olink
glycosyl
tn
antigen
wellknown
human
carcinomaassoci
epitop
sialyl
tn
antigen
moreov
hmgl
bind
group
filovirus
gonorrhea
via
lipooligosaccharid
lead
alter
dc
cytokin
secret
profil
stimul
th
respons
tabl
peptid
tandem
repeat
amino
acid
enzymat
glycosyl
galnac
short
peptid
contain
tn
bound
immatur
dc
glycopeptid
local
within
mhc
class
class
ii
compart
glycopeptid
link
antimgl
antibodi
led
upregul
human
dc
cell
surfac
molecul
enhanc
stimul
vitro
mice
mgl
dc
bound
glycosyl
tn
antigen
vivo
stimul
mhc
class
ii
tcell
respons
intraderm
immun
tnglycopeptid
gener
antibodi
cytokin
secret
cell
recent
mimic
galactosenacetylgalactosamin
stimul
blood
monocyt
myeloid
deriv
dc
suggest
glycosyl
mimet
could
use
target
antigen
mgl
express
dc
result
demonstr
target
mgl
receptor
express
murin
human
dc
stimul
tcell
antibodi
respons
approach
could
use
design
novel
anticanc
vaccin
dendrit
cellassoci
ctype
betaglucan
receptor
ctype
lectin
receptor
part
nk
gene
complex
cluster
tabl
figur
origin
character
dc
specif
henc
name
known
also
express
myeloid
dc
dc
dermal
dc
monocyt
macrophag
neutrophil
microglia
tcell
subset
b
cell
mast
cell
eosinophil
monocyt
receptor
betaglucan
recogn
glucan
yeast
mycobacteri
plant
cell
wall
play
role
innat
immun
respons
zymosan
betaglucan
mannanrich
ligand
bind
interact
tetraspanin
molecul
bind
saccharomyc
candida
pneumocysti
coccidiod
penicillium
aspergillu
cryptococcu
fungal
speci
lead
activ
cell
elimin
fungal
pathogen
activ
inflammatori
respons
tnfalpha
gmcsf
presenc
itam
cytoplasm
tail
fact
knockout
mice
highli
suscept
pathogen
infect
due
inflammatori
defect
reduc
fungal
kill
furthermor
bind
bacteria
result
tnfalpha
rant
gcsf
secret
stimul
inflammatori
cytokin
lead
propos
target
solubl
antigen
appropri
ligand
stimul
cellular
immun
monoclon
antibodi
conjug
ova
induc
signific
expans
cell
drain
lymph
node
mice
ifngamma
secret
cell
purifi
saccharomyc
cerevisia
cell
wall
free
mannan
protein
bind
receptor
dc
conjug
ova
matur
bone
marrow
deriv
dc
rapidli
phagocytos
stimul
effici
oti
otii
cell
compar
ova
alon
immun
mice
stimul
antibodi
cell
ifngamma
bias
respons
thu
robust
stimul
humor
cellular
immun
respons
result
follow
immun
vaccin
candid
target
receptor
nk
lectin
group
group
v
ctype
lectinlik
type
ii
membran
protein
locat
close
encod
within
nk
gene
complex
express
murin
dc
dc
dc
cell
b
cell
cell
nk
cell
nkt
cell
macrophag
granulocyt
plasmacytoid
dc
small
subset
human
blood
dc
dc
monocyt
induc
proinflammatori
cytokin
also
express
interstiti
dc
skin
epidermi
gmcsf
deriv
bone
marrow
dc
highli
express
ligand
bone
marrow
deriv
dc
low
hi
monoclon
antibodi
coval
conjug
peptid
ova
induc
oti
tcell
prolifer
ifngamma
secret
vivo
dc
plasmacytoid
dc
involv
present
peptid
cell
presenc
ctl
prime
vivo
prevent
ova
express
tumor
cell
growth
inject
monoclon
antibodyova
conjug
mice
endocytoz
dc
present
antigen
cell
play
major
role
differenti
cell
regulatori
cell
addit
adjuv
poli
c
enhanc
mediat
immun
wherea
adjuv
curdlan
prime
cell
addit
vaccinia
viru
infect
die
cell
endocytoz
dc
mediat
crossprim
antivaccinia
viru
infect
cell
tcell
respons
loss
impair
ctl
respons
thu
regul
crosspresent
viral
antigen
could
assess
target
vaccin
protocol
furthermor
singl
inject
monoclon
antibodi
induc
strike
antibodi
cell
respons
absenc
adjuv
danger
signal
mice
tlr
knockout
mice
target
antigen
show
promis
enhanc
vaccin
effici
inde
monoclon
antibodi
conjug
hiv
induc
strong
tcell
respons
mice
could
prove
use
develop
immunotherapi
protocol
cancer
diseas
micl
micl
myeloid
inhibitori
ctype
lectinlik
receptor
homolog
part
cluster
numer
group
identifi
receptor
name
ctype
lectinlik
dc
associatedctyp
lectin
killer
cell
lectinlik
receptor
micl
express
granulocyt
monocyt
macrophag
b
cell
cell
peripher
blood
dc
tabl
contain
tyrosin
base
inhibitori
motif
cytoplasm
tail
similar
lectinlik
receptor
oxid
densiti
inhibit
cellular
activ
henc
micl
neg
regul
granulocyt
monocyt
micl
rang
function
includ
cell
adhes
cellcel
signal
turnov
glycoprotein
inflamm
immun
respons
also
known
ctype
lectinlik
receptor
express
nk
cell
dc
monocyt
granulocyt
platelet
megakaryocyt
liver
sinusoid
endotheli
cell
tabl
platelet
activ
receptor
endogen
ligand
podoplanin
mucinlik
sialoglycoprotein
express
number
cell
includ
lymphat
endotheli
cell
implic
cancer
cell
metastasi
platelet
bind
facilit
spread
immun
cell
bind
platelet
via
highli
depend
dcsign
suggest
two
coexist
addit
snake
venom
rhodocytin
bind
platelet
activ
cell
signal
much
known
stimul
immun
respons
express
dc
coloc
dcsign
suggest
may
immun
stimulatori
effect
macrophag
antigen
h
part
nk
gene
cluster
ctype
lectin
receptor
highli
express
macrophag
monocyt
dc
contain
immunoinhibitori
sequenc
cytoplasm
tail
much
known
regard
function
dc
macrophag
possibl
could
use
receptor
target
antigen
immunotherapi
studi
diseas
includ
cancer
howev
still
determin
lectinlik
receptor
oxid
densiti
part
cluster
ctype
lectin
receptor
also
consid
member
scaveng
receptor
famili
express
endotheli
cell
smooth
muscl
cell
platelet
fibroblast
macrophag
bind
gramposit
gramneg
bacteria
oxidizedldl
modifi
lipoprotein
phospholipid
apoptot
cell
creactiv
protein
heat
shock
protein
hsp
contain
classic
signal
motif
cytoplasm
tail
involv
endocytosi
phagocytosi
cytokin
product
product
reactiv
oxygen
speci
consequ
bind
dcmediat
antigen
crosspresent
result
monoclon
antibodi
inhibit
bind
dc
also
inhibit
induc
crosspresent
antigen
monoclon
antibodi
link
ova
protein
specif
stimul
ova
tcell
hybridoma
vitro
measur
product
inject
conjug
mice
prevent
growth
ova
express
tumor
cell
henc
target
promis
target
cancer
immunotherapi
studi
dcir
dcir
dc
immunoreceptor
ctype
lectin
receptor
tyrosin
base
immuneinhibitori
function
dcir
primarili
express
plasmacytoid
dc
pdc
immatur
matur
monocytederiv
dc
monocyt
macrophag
b
cell
matur
pdc
dcir
reduc
tabl
bind
pdc
induc
ifnalpha
inhibit
dcir
activ
whilst
costimulatori
molecul
affect
dcir
rang
function
includ
cell
adhes
cellcel
signal
turnov
glycoprotein
inflamm
immun
respons
target
dcir
rapidli
intern
clathrin
pit
process
present
cell
antidcir
monoclon
antibodi
rapidli
intern
human
monocyt
deriv
dc
endolysosom
vesicl
unregul
mediat
upregul
costimulatori
molecul
inhibit
mediat
tnfalpha
product
thu
target
dcir
activ
cell
also
inhibit
tnfalpha
product
ifnalpha
product
may
appli
vaccin
develop
diseas
prevent
treatment
target
antigen
dcir
evalu
potenti
stimul
tcell
respons
antidcir
monoclon
antibodi
link
influenza
matrix
protein
melanoma
antigen
hiv
gag
antigen
result
expans
cell
vitro
stimul
cell
vivo
addit
agonist
enhanc
expans
prime
cell
induc
product
ifngamma
tnfalpha
reduc
level
cytokin
clear
antigen
target
via
dcir
activ
specif
tcell
immun
respons
betaglucan
receptor
ctype
lectin
receptor
express
dc
macrophag
neutrophil
monocyt
tabl
receptor
betaglucan
recogn
glucan
yeast
mycobacteri
plant
cell
wall
play
role
innat
immun
respons
monoclon
antibodi
conjug
antigen
stimul
cell
mice
addit
lentivector
use
mous
gene
promot
taken
bone
marrow
deriv
dc
langerhan
cell
dermal
dc
vitro
lentivector
encod
human
melanoma
antigen
stimul
cell
mice
thu
express
dc
potenti
target
protein
vaccin
blood
dc
antigen
type
ii
ctype
lectin
express
human
blood
dc
homolog
murin
homolog
monoclon
antibodi
rapidli
intern
plasmacytoid
dc
present
cell
suppress
induct
ifnalphabeta
cytokin
secret
lymphocyt
antigen
ly
typei
integr
membran
protein
homolog
macrophag
mr
famili
ctype
lectin
bind
carbohydr
mediat
endocytosi
figur
primarili
express
dc
thymic
epitheli
cell
mediat
number
differ
biolog
function
bind
intern
ligand
process
present
dc
tabl
although
ligand
bind
clear
follow
ligand
bind
rapidli
intern
mean
coat
pit
vesicl
deliv
multivesicular
endosom
compart
resembl
mhc
class
iicontain
vesicl
implic
antigen
present
due
endocyt
properti
promis
receptor
antigen
deliveri
vaccin
target
immunotherapi
upon
dc
matur
upregul
unlik
member
macrophag
mr
famili
attempt
design
vaccin
target
cytosol
tail
fuse
extern
domain
fc
gamma
receptor
studi
stabl
l
cell
transfect
tail
recycl
mhc
iiposit
late
endosomallysosom
vacuol
also
mediat
increas
antigen
present
cell
monoclon
antibodi
conjug
ova
shown
stimul
ovaspecif
cell
lymph
node
dc
dc
inject
conjug
mice
taken
drain
lymph
node
dc
stimul
oti
cell
time
effici
compar
ova
alon
respons
enhanc
vivo
measur
ifngamma
ctl
tumor
protect
addit
antibodi
dc
matur
stimulu
antibodyova
intraderm
inject
mice
rapidli
taken
langerhan
cell
stimul
tcell
respons
langerin
posit
skin
dc
play
major
role
transport
complex
although
langerin
neg
dermal
dc
dc
respons
tcell
stimul
henc
crosstalk
dc
subset
conjug
monoclon
antibodi
melanoma
antigen
tyrosinaserel
protein
induc
tcell
respons
protect
mice
tumor
cell
growth
slow
growth
establish
tumor
addit
monoclon
antibodi
link
survivin
surviv
protein
overexpress
carcinoma
cell
togeth
poli
c
stimul
survivingspecif
tcell
respons
ifngamma
tnfalpha
secret
lytic
mhc
class
ii
cell
cell
deplet
cell
prior
immun
led
enhanc
immun
respons
interestingli
protein
express
breast
cancer
cell
genet
engin
monoclon
antibodi
combin
poli
c
antibodi
elicit
robust
tcell
respons
antibodi
respons
protect
mice
breast
tumor
challeng
hiv
gag
protein
conjug
monoclon
antibodi
hiv
gag
chain
fv
dna
vaccin
taken
dc
stimul
prolifer
ifngamma
secret
cell
isol
hivinfect
donor
similarli
mice
immun
led
ifngamma
tcell
respons
higher
antibodi
level
likewis
prime
dna
vaccin
boost
adenovir
vector
compris
monoclon
antibodi
conjug
ova
gag
togeth
induc
strong
tcell
respons
enhanc
effect
seen
addit
ligand
cpg
ligand
poli
c
ligand
recombin
newcastl
diseas
viru
vaccin
vector
rndv
induc
ifnalpha
ifnbeta
product
dc
matur
immun
rndv
encod
gag
antigen
enhanc
gag
specif
tcell
respons
increas
number
cell
spleen
compar
rndv
encod
gag
antigen
alon
furthermor
mice
protect
challeng
recombin
vaccinia
viru
express
hiv
gag
protein
conjug
monoclon
antibodi
monoclon
antibodi
murin
model
antigen
stimul
antibodi
tcell
respons
anim
model
convers
use
self
antigen
proteolipid
protein
plp
conjug
monoclon
antibodi
toler
cell
vivo
reduc
secret
cell
vitro
tcell
receptor
cell
specif
plp
becam
anerg
henc
target
selfantigen
induc
toler
clear
target
dc
use
direct
antibodyantigen
conjug
repres
novel
method
induc
toler
selfantigen
antitumor
immun
vivo
scaveng
receptor
sr
group
receptor
recogn
modifi
low
densiti
lipoprotein
ldl
oxid
oxldl
acetyl
acldl
figur
scaveng
receptor
given
name
base
scaveng
function
sr
primarili
present
macrophag
intern
endotoxin
oxldl
neg
charg
protein
sr
group
class
b
c
accord
structur
featur
scaveng
receptor
class
mainli
express
macrophag
trimer
domain
cytosol
transmembran
spacer
alphahel
coiledcoil
collagenlik
cysteinrich
domain
tabl
member
includ
marco
ii
class
b
transmembran
region
identifi
ocldl
receptor
member
includ
iii
class
c
transmembran
region
nterminu
locat
extracellularli
receptor
report
bind
oxldl
includ
murin
homolog
macrosialin
mucin
despit
scaveng
function
sr
sr
shown
endocytoz
antigen
present
antigen
mhc
class
ii
stimul
effect
tcell
respons
use
nm
particl
coat
oligonucleotid
polyguanyl
acid
srtarget
agent
show
specif
bind
sr
particl
local
intracellular
vesicl
process
via
endocytot
pathway
earli
exampl
demonstr
immun
respons
gener
maleyl
ova
bound
sr
enhanc
present
stimul
ctl
macrophag
b
cell
maleyl
diphtheria
toxoid
also
immunogen
nonmaleyl
diphtheria
toxoid
gener
enhanc
antibodi
tcell
prolif
respons
likewis
chicken
immun
maleyl
bovin
serum
albumin
yield
immun
respons
via
antibodi
addit
high
level
ifngamma
mrna
detect
splenocyt
compar
nonmaleyl
bovin
serum
antigen
stimul
immun
respons
tropomyosin
shrimp
caus
allerg
respons
individu
induc
domin
cytokin
profil
ige
antibodi
respons
modifi
tropomyosin
maleyl
tropomyosin
divert
respons
domin
proallerg
phenotyp
ifngamma
antiallerg
phenotyp
thu
modif
protein
target
sr
macrophag
elicit
ifngamma
respons
sr
recogn
malondialdehyd
acetaldehyd
adduct
protein
link
hen
egg
lysozym
protein
stabl
adduct
oxid
product
form
immun
mice
result
strong
tcell
prolif
antibodi
respons
marco
sr
class
famili
member
express
murin
macrophag
human
monocytederiv
dc
play
influenti
role
mediat
immun
respons
antimarco
antibodi
link
tumor
lysatepuls
dc
enhanc
tumorreact
ifngamma
produc
cell
reduc
tumor
growth
mice
studi
demonstr
implic
target
antigen
marco
sr
use
human
clinic
dc
vaccin
trial
dcasialoglycoprotein
receptor
dcasgpr
lectinlik
scaveng
receptor
express
monocyt
deriv
dc
tonsillar
interstitialtyp
dc
granulocyt
cell
b
cell
nk
cell
monocyt
langerhan
cell
deriv
dc
tabl
antidcasgpr
monoclon
antibodi
rapidli
intern
earli
endosom
indic
dcasgpr
involv
antigen
captur
process
target
dcasgpr
induc
suppress
tcell
respons
secret
vitro
vivo
henc
target
antigen
dcasgpr
induc
antigen
specif
suppress
cell
dcasgpr
could
util
induc
suppress
immunotherapeut
effect
selfor
nonselfantigen
restrict
macrophag
year
use
identifi
character
macrophag
tissu
function
role
macrophag
biolog
murin
homolog
epiderm
growth
factorlik
modul
contain
mucinlik
hormon
protein
encod
gene
although
highli
express
macrophag
play
role
macrophag
develop
tabl
figur
howev
receptor
found
necessari
induct
regulatori
cell
respons
peripher
immun
toler
ligand
known
much
work
still
requir
understand
role
immun
respons
could
novel
antigen
target
receptor
fire
receptor
express
specif
immatur
dc
weakli
monocyt
macrophag
tabl
rat
antifir
rat
anticir
antibodi
target
fire
cire
receptor
dc
inject
mice
antirat
ig
titr
measur
compar
control
rat
antibodi
antifir
anticir
antibodi
respons
greater
nontarget
control
rat
antibodi
magnitud
respons
equival
seen
cpg
includ
adjuv
convers
target
receptor
express
dc
rat
antibodi
induc
humor
immun
respons
unless
cpg
ad
studi
demonstr
differ
abil
dc
subset
stimul
immun
respons
vivo
dcspecif
transmembran
protein
dcstamp
contain
transmembran
region
sequenc
homolog
multimembran
cell
surfac
receptor
intracellular
cterminu
dcstamp
resid
endoplasm
reticulum
interact
luman
also
known
lzip
immatur
dc
upon
stimul
dcstamp
transloc
golgi
apparatu
express
cell
surfac
upon
matur
dcstamp
specif
express
dc
activ
rest
blood
dc
panel
leukocyt
nonhematopoiet
cell
tabl
dcstamp
lentivir
vectorova
mice
toler
oti
otii
tcell
respons
lead
elimin
function
inactiv
cell
peripher
organ
thymu
binuclear
multinuclear
dc
express
low
level
mhc
class
ii
high
level
suppress
tcell
prolif
respons
block
dcstamp
decreas
number
binuclear
cell
suggest
dcstamp
respons
immunosuppres
effect
binucl
dc
thu
target
antigen
dcstamp
toler
antigen
specif
tcell
respons
vivo
convers
use
dcstamp
promot
driven
construct
link
ova
result
strong
ovaspecif
tcell
respons
vitro
vivo
protect
mice
ova
tumor
challeng
thu
dcstamp
show
promis
target
cancer
vaccin
antigen
target
approach
fc
receptor
fcr
immunoglobulin
link
humor
cellular
immun
respons
also
link
innat
immun
respons
adapt
immun
respons
bind
pathogen
immun
complex
stimul
cell
differ
fcr
class
immunoglobulin
fc
lphar
iga
fc
psilonr
ige
fc
ammar
igg
fc
lpha
egar
iga
igm
type
fc
ammar
fc
ammari
fc
ammarii
fc
ammariii
fc
ammariv
becom
evid
antibodyantigen
complex
present
antigen
effici
antigen
alon
via
fc
ammar
ova
antigen
complex
antiova
antibodi
inject
mice
present
time
effici
cell
compar
ova
alon
interest
studi
demonstr
ammachain
knockout
mice
lack
fc
ammarifc
ammariiifc
ammariv
induc
similar
tcell
respons
mice
compar
wildtyp
mice
howev
tcell
prolif
respons
reduc
fc
ammarifc
ammariifc
ammariii
knockout
mice
compar
wild
type
mice
suggest
fcr
fc
ammariv
take
immun
complex
stimul
tcell
respons
compar
studi
fcr
mr
target
prostat
serum
antigen
psa
psa
antigenanti
psa
antibodi
complex
induc
tcell
respons
howev
mannosepsa
stimul
cell
howev
given
antigen
mannosyl
appropri
form
cell
could
gener
seen
oxid
versu
reduc
conjug
tabl
fc
ammariii
also
known
conjug
tetanu
toxoid
amino
acid
peptid
hepat
c
viru
peptid
antibodi
activ
tcell
clone
time
effect
compar
peptid
alon
henc
fc
ammariii
properti
antigen
uptak
process
present
cell
effect
immun
respons
gener
fc
lphari
express
myeloid
cell
interstitialtyp
dc
dc
monocyt
deriv
dc
fc
bind
porphyromona
gingivali
bordetella
pertussi
candida
albican
stimul
effici
immun
respons
elimin
crosslink
fc
lphari
induc
intern
receptor
activ
dc
howev
minim
antigen
present
therefor
unlik
target
antigen
human
fcalphari
result
gener
increas
immun
respons
fc
psilonrii
type
transmembran
ctype
lectin
bind
low
affin
ige
also
interact
unlik
fc
receptor
ctype
lectin
main
function
allerg
respons
express
activ
b
cell
activ
macrophag
eosinophil
platelet
follicular
dc
noncoval
associ
dcsign
mhc
class
ii
surfac
human
b
cell
follow
endocytosi
antibodi
lost
cell
howev
endocytosi
antimhc
class
ii
antibodi
lead
recycl
complex
cell
surfac
consist
recycl
mhc
class
ii
antigen
present
intern
cytoplasm
organel
resembl
compart
peptid
load
mhc
class
ii
vesicl
may
lead
peptid
present
return
mhc
class
ii
cell
surfac
may
aid
stabil
bcelltcel
interact
lead
tcell
respons
appar
human
murin
b
cell
take
igeantigen
complex
via
present
antigen
peptid
via
mhc
class
ii
stimul
cell
tnp
trinitrophenyl
specif
ige
link
bsa
ova
inject
mice
result
enhanc
igg
antibodi
respons
compar
either
ige
bsa
ova
inject
alon
enhanc
antibodi
effect
complet
depend
addit
coexpress
dcsign
suggest
antigen
present
stimul
antigen
possibl
crosstalk
two
receptor
henc
target
novel
vaccin
strategi
stimul
tcell
immun
respons
promis
strategi
improv
immunogen
antigen
antigen
target
dc
uniqu
abil
present
antigen
naiv
cell
henc
play
major
role
initi
immun
respons
character
dc
receptor
aid
understand
mechan
underli
potent
antigen
present
capac
major
challeng
vaccin
design
target
antigen
dc
vivo
facilit
crosspresent
condit
microenviron
immun
respons
analys
numer
dc
cell
surfac
receptor
function
induc
cellular
respons
individu
show
promis
target
vaccin
design
cancer
recent
upsurg
inform
regard
tolllik
receptor
tlr
target
stimul
dc
via
tlr
clear
mice
use
tlr
ligand
activ
dc
stimul
effect
cellular
immun
respons
activ
dc
howev
substanti
tlrtarget
vaccin
trial
complet
human
remain
determin
whether
tlr
target
approach
result
signific
benefit
human
seen
mice
furthermor
target
antigen
chemokin
receptor
dc
gener
enhanc
immun
respons
vitro
vivo
furthermor
bacteri
toxin
dc
bind
peptid
intern
peptid
int
also
target
antigen
dc
howev
target
involv
receptor
target
clear
receptor
target
antigen
promis
new
approach
cancer
immunotherapi
studi
